Studies of sodium fluoride effects (a) on human otosclerotic bone (b) on prevention of experimental osteoporosis in rats (c) synergistic action with phosphates.
D000818:Animals; D001846:Bone Development / Q000187:drug effects; D002113:Calcification, Physiologic / Q000187:drug effects; D003348:Cortisone / Q000009:adverse effects; D046508:Culture Techniques; D004429:Ear Ossicles / Q000187:drug effects; D005453:Fluorescence; D005459:Fluorides / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D007274:Injections, Intraperitoneal; D008722:Methods; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control*; D010040:Otosclerosis / Q000188:drug therapy; D010280:Parathyroid Glands / Q000502:physiology; D010710:Phosphates / Q000627:therapeutic use*; D011188:Potassium; D051381:Rats; D012964:Sodium; D013752:Tetracycline; D013997:Time Factors; D014466:Ultraviolet Rays
D010710:Phosphates; D006493:Heparin; D012964:Sodium; D013752:Tetracycline; D005459:Fluorides; D011188:Potassium; D003348:Cortisone